Hetastarch as a prime for cardiopulmonary bypass.

Authors

D A Palanzo
G V Parr
A P Bull
D R Williams
M J O'Neill
J A Waldhausen

Publication/Presentation Date

12-1-1982

Abstract

Hetastarch, a synthetic colloid osmotic plasma volume expander, was employed in a prime for cardiopulmonary bypass in 37 patients undergoing myocardial revascularization. Comparison of laboratory values to those of 42 patients undergoing myocardial revascularization using an albumin-containing prime showed lower postoperative platelet counts (p less than 0.02) with hetastarch. There were no differences in chest tube drainage, blood use, plasma hemoglobin, fibrinogen levels, of coagulation times. The hetastarch prime cost $119.50 per patient, whereas the albumin-containing prime cost $321.35 per patient.

Volume

34

Issue

6

First Page

680

Last Page

683

ISSN

0003-4975

Published In/Presented At

Palanzo, D. A., Parr, G. V., Bull, A. P., Williams, D. R., O'Neill, M. J., & Waldhausen, J. A. (1982). Hetastarch as a prime for cardiopulmonary bypass. The Annals of thoracic surgery, 34(6), 680–683. https://doi.org/10.1016/s0003-4975(10)60908-3

Disciplines

Medicine and Health Sciences

PubMedID

6184024

Department(s)

Department of Medicine

Document Type

Article